Omeros Corporation today reported analyses of Phase 3 clinical data showing the impact of OMS302 on reducing the incidence of miosis (pupil constriction) during intraocular lens replacement. OMS302 is the company’s proprietary Pharmacosurgery product b…
Adding corticosteroid fluocortolone with standard therapy improves visual acuity in NAION patients
Nonarteritic anterior ischemic optic neuropathy is one of the leading causes of sudden and irreversible loss of vision in older adults. In a prospective randomized trial of 60 patients with NAION, investigators have shown that the addition of the corti…
Glaucoma risk double for long-term oral contraceptive users
Research presented at the 117th Annual Meeting of the American Academy of Ophthalmology in New Orleans, has found that women who have taken oral contraceptives for three or more years are twice as likely to suffer from glaucoma, one of the leading caus…
Innovative way to study body glucose regulation
Researchers at Karolinska Institutet in Sweden have found an innovative way to study glucose regulation in the body: by transferring the vital insulin-producing cells from the pancreas to the eye, the latter can serve as a kind of window through which …
Risky heart rhythm may be identified via small vessel changes in eye, kidney
People with damage in the small blood vessels of the retina and kidneys are at increased risk to develop the most common type of abnormal heart rhythm, according to research presented at the American Heart Association’s Scientific Sessions 2013.Atrial …
The eyes are the window to…the pancreas?
A part of the pancreas that produces and secretes insulin – and is therefore essential for maintaining normal blood sugar levels or responsible for diabetes – is largely inaccessible. But now, researchers have found a way to study the insulin-producing…